QIAGEN N.V. Cost of Revenue | QGEN

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue QIAGEN N.V.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	801 M	638 M	521 M	501 M	495 M	493 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
801 M	493 M	575 M

Cost of Revenue of other stocks in the Diagnostics research industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Heska Corporation HSKA	146 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	4.57 M	-	-20.0 %	$ 1.06 M	USA
Syneos Health SYNH	4.14 B	-	-	$ 4.46 B	USA
Motus GI Holdings MOTS	81 K	-	-34.28 %	$ 263 K	Israel
Renalytix AI plc RNLX	2.13 M	-	5.66 %	$ 22.7 M	Britain
Chembio Diagnostics CEMI	38.6 M	-	0.22 %	$ 16.8 M	USA
Psychemedics Corporation PMD	12.6 M	-	-1.84 %	$ 15.3 M	USA
Quotient Limited QTNT	23.6 M	-	-11.32 %	$ 1.1 M	Schweiz
T2 Biosystems TTOO	21 M	-	-39.35 %	$ 313 K	USA
DermTech DMTK	15 M	-	-11.32 %	$ 2.94 M	USA
Bioventus BVS	180 M	$ 13.0	1.39 %	$ 866 M	USA
DarioHealth Corp. DRIO	9.69 M	$ 6.75	2.31 %	$ 26.9 M	Israel
Akumin AKU	608 M	-	-17.87 %	$ 25.9 M	Canada
Accelerate Diagnostics AXDX	8.99 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	28.4 M	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	15.3 M	$ 1.56	17.29 %	$ 8.49 M	USA
Burning Rock Biotech Limited BNR	137 M	$ 11.68	0.69 %	$ 123 M	China
CareDx, Inc CDNA	45.5 M	$ 52.64	0.52 %	$ 2.81 B	USA
Co-Diagnostics CODX	222 K	$ 1.14	2.7 %	$ 1.52 M	USA
Castle Biosciences CSTL	71 M	$ 35.5	6.16 %	$ 1.03 B	USA
Quest Diagnostics Incorporated DGX	7.37 B	$ 247.08	3.9 %	$ 27.4 B	USA
Meridian Bioscience VIVO	145 M	-	-	$ 1.49 B	USA
Biomerica BMRA	4.09 M	$ 2.3	0.42 %	$ 6.7 M	USA
Fulgent Genetics FLGT	192 M	$ 21.28	3.05 %	$ 655 M	USA
Guardant Health GH	349 M	$ 175.65	4.65 %	$ 22 B	USA
ICON Public Limited Company ICLR	6.08 B	$ 172.45	2.08 %	$ 13.5 B	Irlanda
IDEXX Laboratories IDXX	1.64 B	$ 510.73	0.23 %	$ 41.1 B	USA
Danaher Corporation DHR	10 B	$ 209.36	3.01 %	$ 149 B	USA
Illumina ILMN	1.47 B	$ 222.29	6.76 %	$ 34.5 B	USA
IQVIA Holdings IQV	10.9 B	$ 269.67	1.51 %	$ 46.4 B	USA
Brainsway Ltd. BWAY	10.4 M	$ 13.46	0.14 %	$ 457 M	Israel
Laboratory Corporation of America Holdings LH	9.94 B	$ 323.97	2.75 %	$ 27 B	USA
Lantheus Holdings LNTH	600 M	$ 100.73	0.41 %	$ 6.8 B	USA
DexCom DXCM	1.86 B	$ 86.45	2.09 %	$ 33.7 B	USA
Myriad Genetics MYGN	248 M	$ 3.88	2.37 %	$ 359 M	USA
ENDRA Life Sciences NDRA	173 K	$ 5.66	1.13 %	$ 4.45 M	USA
NeoGenomics NEO	413 M	$ 18.89	2.61 %	$ 2.42 B	USA
Neogen Corporation NEOG	462 M	$ 12.25	2.51 %	$ 2.66 B	USA
Natera NTRA	158 M	$ 350.78	2.63 %	$ 48 B	USA
OPKO Health OPK	401 M	$ 1.57	0.64 %	$ 1.18 B	USA
Pacific Biosciences of California PACB	114 M	$ 1.34	0.37 %	$ 402 M	USA
Koninklijke Philips N.V. PHG	9.78 B	$ 24.9	1.99 %	$ 23.6 B	Niderland
Personalis PSNL	53.9 M	$ 16.1	0.31 %	$ 1.44 B	USA